Overall, the data reported in this study suggest that the metastatic spread of BCOR-ITD-positive CCSK can be promoted by specific changes in the gene expression profile that enhance the malignant features of cancer cells and whose activity can in principle be counteracted by specific target pharmacological inhibition. The gene discussed is BCOR; the disease is cancer.